Abstract
Aim:
To evaluate whether the newly-synthesized positron emission tomography (PET) tracer, [18F]2-(4′-(methylamino)phenyl)-6-fluoroethoxy- benzothiazole ([18F]O-FEt-PIB), could bind to β-amyloid aggregates in a rat model of Alzheimer's disease (AD) using micro-PET.
Method:
[18F]O-FEt-PIB was synthesized and purified by radio HPLC. PET imaging was performed with a R4 rodent model scanner in 3 model and 3 control rats. Dynamic PET scans were performed for 40 min in each rat following an injection of approximately 37 MBq of [18F]O-FEt-PIB. Static scans were also performed for 15 min in each rat. PET data were reconstructed by a maximum posteriori probability algorithm. On the coronal PET images, regions of interest were respectively placed on the cortex, hemicerebrum [including the hippocampus and thalamus (HT)], and were guided by a 3-D digital map of the rat brain or the brain images of [18F]2-Deoxy-2-fluoro-D-glucose ([18F]FDG) in normal rats. Time-activity curves (TAC) were obtained for the cerebrum and cerebellum. The activity difference value (ADV) between 2 hemicerebrums was also calculated.
Results:
The TAC for [18F]O-FEt-PIB in the cerebrum or cerebellum peaked early (at approximately 2 min), but washed out a little slowly. In the dynamic and static micro-PET images, increased radioactivity was found in the area of the right HT in the model rats where infused with β-amyloid (1–40). No distinct difference of radioactivity was found between the right and left HT areas in the control rats. The ADV(HT) was approximately 14.6% in the AD model rats and approximately 4 times greater than that of the control rats (3.9%).
Conclusion:
To our knowledge, this study is the first to evaluate a small molecular PET probe for the β-amyloid deposits in vivo using micro-PET imaging in an AD-injected rat model. The suitable biological characters showed that the tracer had potential to be developed as a probe for detecting β-amyloid plaques in AD.
Similar content being viewed by others
Article PDF
References
Cai LS, Innis RB, Pike VW . Radioligand development for PET imaging of β-amyloid (Aβ)-current status. Curr Med Chem 2007; 14: 19–52.
Klunk WE, Lopresti BJ, Ikonomovic MD, Lefterov IM, Koldamova RP . Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-β in Alzheimer's disease brain but not in transgenic mouse brain. J Neurosci 2005; 25: 10598–606.
Toyama H, Ye D, Ichise M, Liow JS, Cai LS, Jacobowitz D, et al. PET imaging of brain with the β-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease. Eur J Nucl Med Mol Imag 2005; 32: 593–600.
Cai LS, Ye D, Liow JS, Hong J, Cohen RM, Pike VW, et al. PET imaging of transgenic mice TG2576 using the beta-amyloid radioligand, [C-11]PIB. Neuroimage 2006; 31: T44–T186.
Shimadzu H, Suemoto T, Suzuki M, Shiomitsu T, Okamura N, Kudo Y, et al. Novel probes for imaging amyloid-β: F-18 and C-11 labeling of 2-(4-aminostyryl)benzoxazole derivatives. J Label Compd Radiopharm 2004; 47: 181–90.
Zheng MQ, Yin DZ, Shen YM, Li GC . Syntheses of 2-(p-aminophenyl)-6-substituent-benzothiazoles. Chin J Organ Chem 2007; 27: 1369–73. Chinese.
Mathis CA, Holt DP, Wang Y, Huang GF, Debnath ML, Klunk WE . F-18-labeled thioflavin-T analogs for amyloid assessment. J Nucl Med 2002; 43: p166.
Zheng MQ, Yin DZ, Zhang L, Cheng DF, Wang YX, Cai HC . Synthesis and evaluation of 18F-labelled PIB as amyloid imaging agents. J Label Compd Radiopharm 2007; 50 ( Suppl 1): S401.
Cheng DF, Yin DZ, Li GC, Wang MW, Li SQ, Zheng MQ, et al. Radiolabeling and in vitro and in vivo characterization of [18F]FB-[R8,15,21,L17]-VIP as a PET imaging agent for tumor overexpressed VIP receptors. Chem Biol Drug Design 2006; 68: 319–25.
Zheng MQ, Yin DZ, Qiao JP, Zhang L, Wang YX . Syntheses and evaluation of fluorinated benzothiazole anilines as potential tracers for β-amyloid plaques in Alzheimer's disease. J Fluorine Chem 2008; 129: 210–6.
Wang R, Zhang HY, Tang XC . Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by β-amyloid protein (1–40) in rat. Eur J Pharmacol 2001; 421: 149–56.
Nitta A, Tuktta T, Hasegawa T, Nabeshima T . Continuous infusion of beta-amyloid protein into the rat cerebral ventricle induces learning impairment and neuronal and morphological degeneration. Jpn J Pharmacol 1997; 73: 51–7.
Cai HC, Yin DZ, Zhang L, Yang XF, Xu XY, Liu WG . Preparation and biological evaluation of 2-amino-6-[18F]fluoro-9-(4-hydroxy-3-hydroxy-methylbutyl) purine (6-[18F]FPCY) as a novel PET probe for imaging HSV1-tk reporter gene expression. Nucl Med Biol 2007; 34: 717–25.
Rubins DJ, Melega WP, Lacan G, Way B, Plenevaux A, Luxen A, et al. Development and evaluation of an automated atlas-based image analysis method for microPET studies of the rat brain. NeuroImage 2003; 20: 2100–18.
Mathis CA, Wang Y, Holt DP, Huang GF, Debnath ML, Klunk WE . Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging. Agents J Med Chem 2003; 46: 2740–54.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the Science Foundation of Shanghai (No 06DZ19506) and the National Natural Science Foundation of China (No 20601028).
Rights and permissions
About this article
Cite this article
Zheng, Mq., Yin, Dz., Zhang, L. et al. Biological characters of [18F]O-FEt–PIB in a rat model of Alzheimer's disease using micro-PET imaging. Acta Pharmacol Sin 29, 548–554 (2008). https://doi.org/10.1111/j.1745-7254.2008.00785.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2008.00785.x